Related Experiment Video
Updated: Jun 14, 2025

14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
33.1K
Leveraging tuberculosis programs for future pandemic preparedness: A retrospective look on COVID-19
Whitney Bowen1, Ho Tri1, Sebastian Romero1
1Jackson School of Global Affairs, Yale University, New Haven, Connecticut, United States of America.
PLOS Global Public Health
|September 5, 2024
Summary
Countries with stronger tuberculosis (TB) programs before and during the COVID-19 pandemic experienced better COVID-19 outcomes. Recovering TB treatment coverage improved pandemic resilience.
Area of Science:
- Global Health
- Epidemiology
- Public Health Policy
Background:
- The COVID-19 pandemic severely impacted global healthcare systems, underscoring the need for pandemic preparedness.
- Future pandemics, particularly respiratory diseases, pose a significant threat, with an estimated 30% likelihood in the next decade.
- Tuberculosis (TB) management shares similarities with respiratory disease control, offering a dual benefit for preparedness.
Purpose of the Study:
- To investigate the relationship between tuberculosis (TB) program strength and a country's performance during the COVID-19 pandemic.
- To identify factors contributing to healthcare system resilience in countries managing both TB and COVID-19.
Main Methods:
- Analysis of data from the World Health Organization (WHO), Global Fund, Our World in Data, and national health ministries.
- Hypothesis testing on the correlation between pre-pandemic TB program strength and COVID-19 outcomes.
- Case studies to identify common factors in resilient TB platforms that also performed well during COVID-19.
Main Results:
- Countries with stronger TB programs demonstrated better outcomes regarding COVID-19 incidence and mortality.
- Nations that restored TB treatment coverage to pre-pandemic levels or higher showed improved COVID-19 pandemic performance.
- Key resilience factors included community trust, continuity of care, innovation, inter-sectoral communication, and sustained donor support for TB programs.
Conclusions:
- Strengthening tuberculosis programs can enhance national resilience against future pandemics.
- Maintaining essential health services, like TB treatment, is crucial during global health crises.
- Integrated approaches and strong community engagement are vital for effective pandemic response and disease management.
Related Concept Videos
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Steps in Outbreak Investigation
114
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
114
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316

